Unicycive Therapeutics, Inc. (UNCY) Misses Q1 EPS by 51c

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) reported Q1 EPS of ($0.61), $0.51 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Unicycive Therapeutics, Inc. (UNCY) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• ConAgra Brands dropped from S&P 500
• Honeywell Aerospace to Join S&P 500 & S&P 100; Others to Join S&P MidCap 400 and S&P SmallCap 600